Skip to main content
Clinical Trials/NCT01286662
NCT01286662
Completed
Not Applicable

In Modern Era, Recurrent Desmoids Determine Outcome in Patients With Gardner Syndrome: A Cohort Study of Three Generations of an Adenomatous Polyposis Coli (APC-) Mutation-Positive Family Across 30 Years

Triemli Hospital0 sites105 target enrollmentStarted: January 31, 2011Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
105
Primary Endpoint
mortality

Overview

Brief Summary

The purpose of this study is to assess the long-term outcome in a cohort of Gardner-Syndrome patients receiving prophylaxis and treatment for intestinal and non-intestinal tumors.

Detailed Description

Since 1978, we have been following a family of 105 descendants with Gardner Syndrome (GS). Mutation carriers were screened by endoscopy, and colorectal resection was performed upon pending malignancy. Resectable desmoid tumors were excised, whereas large tumors of the abdominal wall were treated by a combination of brachytherapy (BT) and radiotherapy (RT). Outcome was analyzed with respect to length of tumor-free survival, and morbidity from surgery or radiotherapy. Results: 37 of 105 family members have GS. Preventive colorectal resections were performed in 16 patients (15%), with one death due to subsequent gastric cancer. In 4 patients who denied screening endoscopy, invasive tumors of the colon (3 patients) and stomach (one patient each) developed. Of 33 desmoid tumors, 10 (30%) were located in the mesentery, 17 (52%) in the abdominal wall, and 6 (18%) in extra-abdominal sites. Excision of 12 desmoids was performed in 8 patients (36%), and 4 were treated by a combination of BT and RT. Following BT/RT, all patients showed full or partial remission.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • family with an identical adenomatous polyposis coli (APC-) germ line mutation

Exclusion Criteria

  • negative testing for adenomatous polyposis coli (APC-) germ line mutation

Outcomes

Primary Outcomes

mortality

Time Frame: 1978-2010 (as long as patients live)

Secondary Outcomes

  • incidence of colorectal carcinoma(1978-2010 (entire patient life))
  • Incidence of desmoid tumors(1978-2010 (entire patient life))

Investigators

Sponsor Class
Other

Similar Trials